$2 Trillion Disappears Because of Fed's Secretive New Move

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Mostafa Ronaghi Biography and Net Worth

SVP of Illumina

Dr. Mostafa Ronaghi, Ph.D., has been the Chief Technology Officer and Senior Vice President of Illumina Inc. since 2008 and is responsible for leading internal research and the Illumina accelerator program. Dr. Ronaghi is a Co-Founder of Illumina Accelerator Program. Dr. Ronaghi co-founded NextBio, Inc., in 2004 and served as its Chairman of Scientific Advisory Board. He co-founded Pyrosequencing AB (now Biotage) in Uppsala, Sweden in 1997. He co-founded ParAllele BioScience Inc. in 2001. He co-founded Avantome, Inc. He is an experienced life sciences entrepreneur and was involved in the start-up of four life sciences companies. He served as Principal Investigator of Stanford University Genome Center focused on development of novel tools for molecular diagnostics applications from 2002 to 2008. He is known internationally for his work in DNA-based technologies. He serves as a Member of the Scientific Advisory Board at IntegenX Inc. (formerly, Microchip Biotechnologies, Inc). Dr. Ronaghi serves as a Director of Aurora Algae, Inc. (formerly, Aurora BioFuels Inc) and Clear Labs, Inc. He serves as a Member of Scientific Advisory Board of GRAIL, Inc. Dr. Ronaghi served as a Member of Scientific Advisory Board at ParAllele Bioscience, Inc. He served as a Director of IntegenX Inc. since October 31, 2006. He holds more than 50 pending and issued patents and has written more than 70 peer-reviewed publications in journals and books. Dr. Ronaghi received his PhD from Royal Institute of Technology in Sweden.

What is Mostafa Ronaghi's net worth?: The estimated net worth of Mostafa Ronaghi is at least $11.41 million as of December 10th, 2020. Ronaghi owns 83,862 shares of Illumina stock worth more than $11,406,909 as of December 22nd. This net worth approximation does not reflect any other investments that Ronaghi may own. Learn More about Mostafa Ronaghi's net worth.
How do I contact Mostafa Ronaghi?: The corporate mailing address for Ronaghi and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected]. Learn More on Mostafa Ronaghi's contact information.
Has Mostafa Ronaghi been buying or selling shares of Illumina?: Mostafa Ronaghi has not been actively trading shares of Illumina during the last quarter. Most recently, Mostafa Ronaghi sold 5,000 shares of the business's stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $338.58, for a transaction totalling $1,692,900.00. Following the completion of the sale, the senior vice president now directly owns 83,862 shares of the company's stock, valued at $28,393,995.96. Learn More on Mostafa Ronaghi's trading history.
Who are Illumina's active insiders?: Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Jacob Thaysen (CEO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.
Are insiders buying or selling shares of Illumina?: In the last year, Illumina insiders bought shares 1 times. They purchased a total of 7,330 shares worth more than $991,675.70. The most recent insider tranaction occured on February, 22nd when CEO Jacob Thaysen bought 7,330 shares worth more than $991,675.70. Insiders at Illumina own 0.2% of the company. Learn More about insider trades at Illumina.
Information on this page was last updated on 2/22/2024.

Mostafa Ronaghi Insider Trading History at Illumina

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/10/2020	Sell	5,000	$338.58	$1,692,900.00	83,862
10/15/2019	Sell	4,000	$310.93	$1,243,720.00	80,585
9/16/2019	Sell	10,000	$300.53	$3,005,300.00	86,585
8/15/2019	Sell	10,000	$285.52	$2,855,200.00	86,585
7/15/2019	Sell	10,000	$302.04	$3,020,400.00	86,776
6/17/2019	Sell	10,000	$349.28	$3,492,800.00	65,994
5/15/2019	Sell	10,000	$305.49	$3,054,900.00	87,414
11/12/2018	Sell	10,000	$314.63	$3,146,300.00	79,612
10/10/2018	Sell	10,000	$311.84	$3,118,400.00	80,805
9/10/2018	Sell	10,000	$347.07	$3,470,700.00	80,805
8/10/2018	Sell	10,000	$331.39	$3,313,900.00
7/10/2018	Sell	7,500	$288.89	$2,166,675.00	78,496
6/11/2018	Sell	10,500	$284.83	$2,990,715.00	81,496
5/16/2018	Sell	10,000	$267.71	$2,677,100.00	80,996
9/7/2017	Sell	20,000	$210.00	$4,200,000.00	86,725
8/2/2017	Sell	10,000	$195.00	$1,950,000.00	76,585
7/17/2015	Sell	1,200	$235.00	$282,000.00
7/15/2015	Sell	3,000	$227.19	$681,570.00
12/1/2014	Sell	10,000	$188.46	$1,884,600.00
11/3/2014	Sell	10,000	$195.66	$1,956,600.00
10/1/2014	Sell	10,000	$159.81	$1,598,100.00
9/2/2014	Sell	10,000	$179.66	$1,796,600.00
8/1/2014	Sell	10,000	$159.73	$1,597,300.00
7/1/2014	Sell	10,000	$179.47	$1,794,700.00
6/2/2014	Sell	10,000	$156.93	$1,569,300.00
5/1/2014	Sell	10,000	$135.91	$1,359,100.00	28,604
4/1/2014	Sell	10,000	$152.41	$1,524,100.00	28,604
7/11/2013	Sell	24,000	$74.95	$1,798,800.00
6/11/2013	Sell	24,000	$69.01	$1,656,240.00
5/13/2013	Sell	24,000	$68.83	$1,651,920.00

Mostafa Ronaghi Buying and Selling Activity at Illumina

Illumina Company Overview

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Today's Range

Now: $136.02

$133.08

$137.69

50 Day Range

MA: $143.91

$130.74

$155.15

2 Week Range

Now: $136.02

$100.08

$156.66

Volume

14,354,048 shs

Average Volume

2,058,953 shs

Market Capitalization

$21.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

Click here to see his new research now.